Clinical Trials Browser

sacituzumab govitecan × CNS × 30 days × Clear all

NCT04647916 2026-05-06

Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases

Phase 2 Active not recruiting

Brain Neoplasms